CES2 (carboxylesterase 2)

2007-02-01  

Identity

HGNC
LOCATION
16q22.1
LOCUSID
ALIAS
CE-2,CES2A1,PCE-2,iCE
FUSION GENES

Other Information

Locus ID:

NCBI: 8824
MIM: 605278
HGNC: 1864
Ensembl: ENSG00000172831

Variants:

dbSNP: 8824
ClinVar: 8824
TCGA: ENSG00000172831
COSMIC: CES2

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000172831ENST00000317091O00748
ENSG00000172831ENST00000417689O00748
ENSG00000172831ENST00000561697J3QLP1
ENSG00000172831ENST00000564420J3QSC0
ENSG00000172831ENST00000568470H3BUN5
ENSG00000172831ENST00000570032H3BUN5

Expression (GTEx)

0
50
100
150
200

Pathways

PathwaySourceExternal ID
Drug metabolism - other enzymesKEGGko00983
Drug metabolism - other enzymesKEGGhsa00983
MetabolismREACTOMER-HSA-1430728
Biological oxidationsREACTOMER-HSA-211859
Phase 1 - Functionalization of compoundsREACTOMER-HSA-211945

Protein levels (Protein atlas)

Not detected
Low
Medium
High

PharmGKB

Entity IDNameTypeEvidenceAssociationPKPDPMIDs
PA164748728mycophenolic acidChemicalPathwayassociated24220207
PA165110775SN-38ChemicalPathwayassociated
PA450085irinotecanChemicalPathwayassociated
PA450566mycophenolate mofetilChemicalPathwayassociated24220207

References

Pubmed IDYearTitleCitations
357902452022The COVID-19 Oral Drug Molnupiravir Is a CES2 Substrate: Potential Drug-Drug Interactions and Impact of CES2 Genetic Polymorphism In Vitro.8
361137742022Carboxylesterase 2 induces mitochondrial dysfunction via disrupting lipid homeostasis in oral squamous cell carcinoma.7
357902452022The COVID-19 Oral Drug Molnupiravir Is a CES2 Substrate: Potential Drug-Drug Interactions and Impact of CES2 Genetic Polymorphism In Vitro.8
361137742022Carboxylesterase 2 induces mitochondrial dysfunction via disrupting lipid homeostasis in oral squamous cell carcinoma.7
332911242021Discovery of hCES2A inhibitors from Glycyrrhiza inflata via combination of docking-based virtual screening and fluorescence-based inhibition assays.6
332911242021Discovery of hCES2A inhibitors from Glycyrrhiza inflata via combination of docking-based virtual screening and fluorescence-based inhibition assays.6
318366072020Identification and Characterization of a New Carboxylesterase 2 Isozyme, mfCES2C, in the Small Intestine of Cynomolgus Monkeys.0
319815912020Overexpressed CES2 has prognostic value in CRC and knockdown CES2 reverses L-OHP-resistance in CRC cells by inhibition of the PI3K signaling pathway.10
327790422020LncRNA KCNQ1OT1 ameliorates the liver injury induced by acetaminophen through the regulation of miR-122-5p/CES2 axis.3
318366072020Identification and Characterization of a New Carboxylesterase 2 Isozyme, mfCES2C, in the Small Intestine of Cynomolgus Monkeys.0
319815912020Overexpressed CES2 has prognostic value in CRC and knockdown CES2 reverses L-OHP-resistance in CRC cells by inhibition of the PI3K signaling pathway.10
327790422020LncRNA KCNQ1OT1 ameliorates the liver injury induced by acetaminophen through the regulation of miR-122-5p/CES2 axis.3
308674712019Prognostic Impact of Carboxylesterase 2 in Cholangiocarcinoma.6
308674712019Prognostic Impact of Carboxylesterase 2 in Cholangiocarcinoma.6
285322702018Predominant contributions of carboxylesterase 1 and 2 in hydrolysis of anordrin in humans.0

Citation

Dessen P

CES2 (carboxylesterase 2)

Atlas Genet Cytogenet Oncol Haematol. 2007-02-01

Online version: http://atlasgeneticsoncology.org/gene/43893/ces2